Showing results (1541-1550 of 1,579) with videos related to

Sort By:
Pageof 158
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Cancer Research|January 18, 2020
A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal TumorigenesisKun Liao, Shuye Deng, Liyan Xu, et al.
Cancer Research|June 28, 2022
RNA Helicase DDX24 Stabilizes LAMB1 to Promote Hepatocellular Carcinoma ProgressionTianze Liu, Hairun Gan, Simeng He, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|March 12, 2015
[Epidemiological survey of asthma among children aged 0-14 years in 2010 in urban Zhongshan, China]Juan Huang, Dong-Ming Huang, Xiao-Xiong Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Jinlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2012
Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanineZhicai Wu, Cangming Yang, Yusheng Xiong, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 31, 2007
[Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma]Meng-Zhong Liu, Li-Ru He, Tai-Xiang Lu, et al.
Biomed Research International|December 31, 2019
Association between Neck Circumference and the Occurrence of Cardiovascular Events in Type 2 Diabetes: Beijing Community Diabetes Study 20 (BCDS-20)Guang-Ran Yang, Ming-Xia Yuan, Gang Wan, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanesThomas H Graham, Wensheng Liu, Andreas Verras, et al.
Pageof 158